Search research articles
Contact Us
Filters
Showing results (61-70 of 118) with videos related to
Page
of 12
Sort By:
Journal of Translational Medicine
|
August 13, 2014
Evaluation of tumor response to cytokine-induced killer cells therapy in malignant solid tumors
Xiao-Dong Li, Mei Ji, Xiao Zheng, et al.
European Journal of Immunology
|
September 3, 2011
IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells
Qianting Yang, Gang Li, Yibei Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 2, 2018
Novel Effector Phenotype of Tim-3<sup>+</sup> Regulatory T Cells Leads to Enhanced Suppressive Function in Head and Neck Cancer Patients
Zhuqing Liu, Elizabeth L McMichael, Gulidanna Shayan, et al.
Frontiers in Cell and Developmental Biology
|
December 6, 2021
The Half-Life-Extended IL21 can Be Combined With Multiple Checkpoint Inhibitors for Tumor Immunotherapy
Shaoxian Wu, Runzi Sun, Bo Tan, et al.
Hybridoma (2005)
|
February 26, 2009
Characterization and application of two novel monoclonal antibodies against human CXCR4: cell proliferation and migration regulation for glioma cell line in vitro by CXCR4/SDF-1alpha signal
Zhongqin Cheng, Shiyong Zhou, Xuefeng Wang, et al.
Annals of Neurology
|
May 16, 2013
Adoptive regulatory T-cell therapy protects against cerebral ischemia
Peiying Li, Yu Gan, Bao-Liang Sun, et al.
Oncology Letters
|
August 13, 2020
CD8<sup>+</sup> T cells located in tertiary lymphoid structures are associated with improved prognosis in patients with gastric cancer
Qing Li, Dachuan Zhang, Wenting He, et al.
Journal of Neuroinflammation
|
June 1, 2012
CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery
Moa Fransson, Elena Piras, Joachim Burman, et al.
Journal for Immunotherapy of Cancer
|
July 24, 2025
Specific inhibitor to KRAS<sup>G12C</sup> induces tumor-specific immunity and synergizes with oncolytic virus for enhanced cancer immunotherapy
Zhi Zhu, Hongqi Chen, Chao Feng, et al.
International Immunology
|
August 18, 2009
A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling
Songwen Ju, Songguang Ju, Yan Ge, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 118) with videos related to
Sort By:
Page
of 12
Journal of Translational Medicine
|
August 13, 2014
Evaluation of tumor response to cytokine-induced killer cells therapy in malignant solid tumors
Xiao-Dong Li, Mei Ji, Xiao Zheng, et al.
European Journal of Immunology
|
September 3, 2011
IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells
Qianting Yang, Gang Li, Yibei Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 2, 2018
Novel Effector Phenotype of Tim-3<sup>+</sup> Regulatory T Cells Leads to Enhanced Suppressive Function in Head and Neck Cancer Patients
Zhuqing Liu, Elizabeth L McMichael, Gulidanna Shayan, et al.
Frontiers in Cell and Developmental Biology
|
December 6, 2021
The Half-Life-Extended IL21 can Be Combined With Multiple Checkpoint Inhibitors for Tumor Immunotherapy
Shaoxian Wu, Runzi Sun, Bo Tan, et al.
Hybridoma (2005)
|
February 26, 2009
Characterization and application of two novel monoclonal antibodies against human CXCR4: cell proliferation and migration regulation for glioma cell line in vitro by CXCR4/SDF-1alpha signal
Zhongqin Cheng, Shiyong Zhou, Xuefeng Wang, et al.
Annals of Neurology
|
May 16, 2013
Adoptive regulatory T-cell therapy protects against cerebral ischemia
Peiying Li, Yu Gan, Bao-Liang Sun, et al.
Oncology Letters
|
August 13, 2020
CD8<sup>+</sup> T cells located in tertiary lymphoid structures are associated with improved prognosis in patients with gastric cancer
Qing Li, Dachuan Zhang, Wenting He, et al.
Journal of Neuroinflammation
|
June 1, 2012
CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery
Moa Fransson, Elena Piras, Joachim Burman, et al.
Journal for Immunotherapy of Cancer
|
July 24, 2025
Specific inhibitor to KRAS<sup>G12C</sup> induces tumor-specific immunity and synergizes with oncolytic virus for enhanced cancer immunotherapy
Zhi Zhu, Hongqi Chen, Chao Feng, et al.
International Immunology
|
August 18, 2009
A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling
Songwen Ju, Songguang Ju, Yan Ge, et al.
Page
of 12